How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

933 results for

Fetal Abdominal Circumference

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Fetal 3D Study (Fetal Body Composition and Volumes Study)

additional image and 3D volume acquisition for later analysis. Ultrasound measurements at each follow-up visit included standard fetal biometrics ((BPD, HC, AC, FL) and the following volumes in the singleton study if they were able to be obtained: 1st trimester: fetus and gestational sac; 2nd and 3rd trimesters: head, cerebellum, face, chest, heart, abdomen, pelvis, arm and thigh. In twins, the volumes collected were 1st trimester: fetus and gestational sac and in the 2nd and 3rd trimesters the thigh (...) Outcome Measures Go to Primary Outcome Measures : Standards for fetal body composition and organ volumes by maternal race/ethnicity [ Time Frame: 3 years ] Growth trajectories in singletons and dichorionic twin pregnancies will be created using two- and selected three-dimensional ultrasound measures. Measures in singletons include fetal body composition from 2D abdominal circumference, arm and thigh volumes; cerebellum; adrenal glands; kidneys; liver; pancreas; lungs; first trimester gestational sac

2017 Clinical Trials

42. Fractional Fetal Thigh Volume in the prediction of normal and abnormal fetal growth during the third trimester of pregnancy. Full Text available with Trip Pro

<3rd customized birthweight centile. Logistic regression was used to compare estimated fetal weight (Hadlock), estimated fetal weight (biparietal diameter-abdominal circumference-fractional thigh volume), fractional thigh volume, and abdominal circumference for the prediction of small for gestational age or fetal growth restriction at birth. Screening performance was assessed using area under the receiver operating characteristic curve.There was a better correlation between fractional thigh volume (...) and estimated fetal weight ((biparietal diameter-abdominal circumference-fractional thigh volume) obtained at 34-36 weeks with birthweight than between 2-dimensional biometry measures such as abdominal circumference and estimated fetal weight (Hadlock). There was also a modest improvement in the detection of both small for gestational age and fetal growth restriction using fractional thigh volume-derived measures compared to standard 2-dimensional measurements (area under receiver operating characteristic

2017 American Journal of Obstetrics and Gynecology

43. Modulation of the Intestinal Flora With the Probiotic VIVOMIXXâ„¢ in Pregnant Women at Risk of Metabolic Complications

to the patients at each visit. Height will be assessed at Visit 1, while the following parameters will be measured at each visit: weight, waits/hip circumference ratio, arterial blood pressure, plasma hemoglobin (Hb), hematocrit (Ht), fasting glycemia, fasting insulin and fasting glycated hemoglobin (HbA1c1). A blood sample for the evaluation of homocysteine will be taken as well as urine and a faeces sample will be collected for nuclear-magnetic-resonance (NMR)-based metabolomics and intestinal microbiota (...) analysis. Furthermore, an Arm-band will be positioned for monitoring sleep and physical activities for one week at each visit. At Visit 2 and 3 data regarding ultrasound examinations (Amniotic fluid index, abdominal circumference, cephalic circumference ratio) will be also collected. Two-three days after delivery (Visit 4) data regarding the delivery (mode of delivery, gestational age at delivery) as well as the newborn (Apgar score, glycemia and serum bilirubin) were collected. Moreover, a sample

2016 Clinical Trials

44. Head Circumference

Head Circumference Head Circumference Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Head Circumference Head Circumference Aka: Head (...) Circumference , Microcephaly , Microcephalic Infant , Macrocephaly , Macrocephalic Infant II. Exam: Head Size Measurement Normal term newborn Head Circumference: 33 to 38 cm Technique Measuring tape around frontal forehead and occiput Take largest of several measurements III. Causes: Macrocephaly Familial with inheritance Other conditions (skeletal dysplasia) Sotos' Syndrome ( ) Alexander's Disease Canavan's Disease Gangliosidoses Glutaric aciduria Type I Type I IV. Causes: Microcephaly Familial Trisomy 13

2018 FP Notebook

45. Antenatal corticosteriods given to women prior to birth to improve fetal, infant, child and adult health

or gestational diabetes at risk of preterm birth 210 14.8 Women with systemic infection at trial entry at risk of preterm birth 224 14.9 Women with pregnancy associated hypertension/pre-eclampsia at risk of preterm birth 226 14.10 Women with a fetus with intrauterine growth restriction at risk of preterm birth 238 Page 2 14.11 Women with ultrasound evidence of cervical shortening /funnelling 249 14.12 Fetal fibronectin test and the use of antenatal corticosteroids in women at risk of preterm birth . 251 (...) with a fetus with intrauterine growth restriction at risk of preterm birth – Repeat course of antenatal corticosteroids 444 M35 Women with ultrasound evidence of cervical shortening /funnelling – Single course or repeat antenatal corticosteroids 448 M36 Fetal fibronectin test and the use of antenatal corticosteroids in women at risk of preterm birth – Single course or repeat antenatal corticosteroids 452 M37 Women for whom preterm birth is medically indicated for other reasons – Single course of antenatal

2015 Clinical Practice Guidelines Portal

46. Association of first trimester maternal vitamin D, ferritin and hemoglobin level with third trimester fetal biometry: result from cohort study on vitamin D status and its impact during pregnancy and childhood in Indonesia. Full Text available with Trip Pro

and 43 women (21%) were in insufficient state. Women with insufficient vitamin D had the highest proportion of anemia, while women with normal vitamin D level had the highest proportion of low ferritin level. Maternal serum vitamin D showed significant associations with biparietal diameter (β = 0.141, p = 0.042) and abdominal circumference (β = 0.819, p = 0.001) after adjustment with maternal age, pre-pregnancy body mass index, parity, serum ferritin level, and hemoglobin level.Our study suggested (...) Association of first trimester maternal vitamin D, ferritin and hemoglobin level with third trimester fetal biometry: result from cohort study on vitamin D status and its impact during pregnancy and childhood in Indonesia. The role of vitamin D in placental functions and fetal growth had been addressed in many reports with conflicting results. However, such report is limited for Indonesian population. The aim of this study was to explore the association between maternal vitamin D level

2019 BMC Pregnancy and Childbirth

47. Etiology and perinatal outcome in periviable fetal growth restriction associated with structural or genetic anomalies. (Abstract)

Etiology and perinatal outcome in periviable fetal growth restriction associated with structural or genetic anomalies. To investigate the aetiology and the perinatal outcome of fetuses diagnosed with periviable fetal growth restriction (FGR) associated with structural defects or genetic anomalies.Retrospective study conducted at a referral Fetal Medicine unit. Singleton pregnancies seen between 2005 and 2018 in which FGR, defined by fetal abdominal circumference ≤3rd percentile

2019 Ultrasound in Obstetrics and Gynecology

48. Maternal cardiometabolic markers are associated with fetal growth: a secondary exploratory analysis of the LIMIT randomised trial. Full Text available with Trip Pro

of registration 9/03/2007, prospectively registered). Fetal biometry including abdominal circumference (AC), estimated fetal weight (EFW), and adiposity measurements (mid-thigh fat mass, subscapular fat mass, abdominal fat mass) were obtained from ultrasound assessments at 28 and 36 weeks' gestation. Maternal markers included C reactive protein (CRP), leptin and adiponectin concentrations, measured at 28 and 36 weeks' gestation and fasting triglycerides and glucose concentrations measured at 28 weeks (...) Maternal cardiometabolic markers are associated with fetal growth: a secondary exploratory analysis of the LIMIT randomised trial. To determine the association between maternal cardiometabolic and inflammatory markers with measures of fetal biometry and adiposity.Women included in this exploratory analysis were randomised to the 'Standard Care' group (N = 911) from the LIMIT randomised trial involving a total of 2212 pregnant women who were overweight or obese (ACTRN12607000161426, Date

2019 BMC Endocrine Disorders

49. Blood-based biomarkers in the maternal circulation associated with fetal growth restriction. Full Text available with Trip Pro

Blood-based biomarkers in the maternal circulation associated with fetal growth restriction. Fetal growth restriction (FGR) is associated with threefold to fourfold increased risk of stillbirth. Identifying FGR, through its commonly used surrogate-the small-for-gestational-age (SGA, estimated fetal weight and/or abdominal circumference <10th centile) fetus-and instituting fetal surveillance and timely delivery decrease stillbirth risk. Methods available to clinicians for antenatal (...) potential biomarkers to date have utilised case-control study designs without proceeding to validation in independent cohorts. To develop a robust test for FGR, large prospective studies are required with a priori validation plans and cohorts. Given that current clinical care detects 20% of SGA fetuses, even a screening test with ≥60% sensitivity at 90% specificity could be clinically useful, if developed. This may be an achievable aspiration. If discovered, such a test may decrease stillbirth.© 2019

2019 Prenatal diagnosis

50. Role of Doppler ultrasound in predicting perinatal outcome in pregnancies complicated by late-onset fetal growth restriction at the time of diagnosis: a prospective cohort study. (Abstract)

and predictive accuracy of maternal and fetal Dopplers in predicting perinatal outcome of fetuses affected by late-onset FGR at the time of diagnosis.Prospective study of consecutive singleton pregnancies complicated by late-onset FGR. Estimated fetal weight (EFW), pulsatility index (PI) in the uterine, umbilical (UA), and middle cerebral (MCA) arteries, cerebro-placental ratio (CPR) and umbilical vein flow (normalized for fetal abdominal circumference) (UVBF/AC) were recorded at the time of the diagnosis (...) Role of Doppler ultrasound in predicting perinatal outcome in pregnancies complicated by late-onset fetal growth restriction at the time of diagnosis: a prospective cohort study. Pregnancies complicated by late-onset fetal growth restriction (FGR) are at increased risk of short- and long-term morbidities. Despite this, identification of cases at higher risk of adverse perinatal outcome when FGR is diagnosed is challenging. The aims of this study were to elucidate the strength of association

2019 Ultrasound in Obstetrics and Gynecology

51. Antenatal detection of fetal growth restriction and stillbirth risk: a population-based case-control study. (Abstract)

customized standards. Detection of fetal growth restriction (FGR) was defined by the presence of at least one of seven predefined parameters (FGR or growth faltering mentioned in medical records or ultrasound reports, documented abdominal circumference or estimated fetal weight <10th percentile, prescription of additional ultrasounds to monitor growth or abnormal umbilical Doppler). We used logistic regression to estimate crude and adjusted odds ratios (OR) of the association of detection with stillbirth (...) Antenatal detection of fetal growth restriction and stillbirth risk: a population-based case-control study. Antenatal surveillance of intrauterine growth aims to detect growth restricted fetuses who face higher risks of stillbirth. Improving detection could be an effective strategy for stillbirth prevention. The REPERE study was conducted to estimate the association between antenatal detection of small for gestational age (SGA) and stillbirth risk in France.REPERE is a case-control study

2019 Ultrasound in Obstetrics and Gynecology

52. Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial. Full Text available with Trip Pro

, the Dutch trial was stopped prematurely due to excess neonatal mortality secondary to pulmonary hypertension. The main aim of this study was to investigate the effect of sildenafil on maternal hemodynamics in pregnancies with severe early-onset FGR.In this UK multicenter, placebo-controlled trial, we randomly assigned 135 women with singleton pregnancies and severe early-onset FGR (defined as a combination of estimated fetal weight or abdominal circumference below the 10th centile and absent/reversed (...) Effect of sildenafil on maternal hemodynamics in pregnancies complicated by severe early-onset fetal growth restriction: planned subgroup analysis from a multicenter randomized placebo-controlled double-blind trial. Fetal growth restriction (FGR) is associated with maternal cardiovascular changes. Sildenafil, a phosphodiesterase type 5 inhibitor, potentiates the actions of nitric oxide and has been proposed to alter maternal hemodynamics, potentially improving placental perfusion. Recently

2019 Ultrasound in Obstetrics and Gynecology Controlled trial quality: predicted high

53. In overweight and obese women, fetal ultrasound biometry accurately predicts newborn measures. (Abstract)

) and adiposity measures including mid-thigh fat mass (MTFM), subscapular fat mass (SSFM), and abdominal fat mass (AFM) were undertaken using ultrasound. Neonatal anthropometric measurements obtained after birth included birthweight, head circumference (HC), abdominal circumference (AC) and skinfold thickness measurements (SFTM) of the subscapular region and abdomen.At 36 weeks gestation, every 1 g increase in EFW was associated with a 0.94 g increase in birthweight (95% CI 0.88-0.99; P < 0.001). For every 1 (...)  mm increase in the fetal ultrasound measure, there was a 0.69 mm increase in birth HC (95% CI 0.63-0.75, P < 0.001) and 0.69 mm increase in birth AC (95% CI 0.60-0.79, P < 0.001). Subscapular fat mass in the fetus and the newborn (0.29 mm, 95% CI 0.20-0.39, P < 0.001) were moderately associated, but AFM measurements were not (0.06 mm, -0.03 to 0.15, P = 0.203). There is no evidence that these relationships differed by maternal body mass index.In women who are overweight or obese, fetal ultrasound

2019 The Australian & New Zealand journal of obstetrics & gynaecology Controlled trial quality: uncertain

54. Reduced fetal growth velocities and the association with neonatal outcomes in appropriate-for-gestational-age neonates: a retrospective cohort study. Full Text available with Trip Pro

restriction of growth potential. We hypothesized that within AGA neonates, reduced fetal growth velocities are associated with adverse neonatal outcome.A retrospective cohort study of singleton pregnancies, in the Maastricht University Medical Centre (MUMC) between 2010 and 2016. Women had two fetal biometry scans (18-22 weeks and 30-34 weeks of gestational age) and delivered a newborn with a birth weight between the 10th-80th percentile. Differences in growth velocities of the abdominal circumference (AC (...) velocity and neonates with NICU stay (OR) = 0.733 (95%CI 0.570-0.942, p = 0.015). Neonates with a birthweight lower than expected (based on the abdominal circumference at 20 weeks) had significantly more composite adverse neonatal outcomes 8.5% vs 5.0% (p = 0.047), NICU stays 9.6% vs 3.8% (p < .0001) and hospital stays 44.4% vs 35.6% (p = 0.006).Appropriate-for-gestational-age neonates are a heterogeneous group with some showing suboptimal fetal growth. Abnormal fetal growth velocities, especially

2019 BMC Pregnancy and Childbirth

55. Does fetoscopic or open repair for spina bifida affect fetal and postnatal growth? (Abstract)

effect on the fetal, neonatal or infant biometric percentiles.Fetuses which underwent fetoscopic repair had a larger abdominal circumference percentile at referral (57 ± 21 vs 46 ± 23; P = 0.04). There were no other differences between the two groups in fetal biometric percentiles at the time of referral, 6 weeks post-surgery or at birth. There were no differences between groups in EFW percentile or in proportions of cases with birth weight < 10th and < 3rd percentiles. Linear mixed-model analysis (...) did not show any significant differences in any fetal growth parameter between the groups over time. There were no significant correlations between duration of surgery or duration of CO2 exposure and any of the biometric percentiles evaluated. Postnatal growth showed no significant differences between the groups in weight, height or head circumference percentiles, at 6-18, 18-30 or > 30 months of age.Babies exposed to fetoscopic or open MMC repair in-utero did not show significant differences

2019 Ultrasound in Obstetrics and Gynecology

56. Gestational age at diagnosis of early-onset fetal growth restriction and impact on management and survival: a population-based cohort study Full Text available with Trip Pro

to discharge. 50% were live born when diagnosis occurred before 25 weeks, 66% at 25 weeks and >90% at 26 and 27 weeks of gestation. In all, 94.1% of live births were by prelabour caesarean, principally for maternal indications before 26 weeks. Low GA at diagnosis, an estimated fetal weight or abdominal circumference below the third centile and male sex were adversely associated with live birth in adjusted models.Gestational age at FGR diagnosis had an impact on the probability of live birth and survival (...) Gestational age at diagnosis of early-onset fetal growth restriction and impact on management and survival: a population-based cohort study To investigate the impact of gestational age (GA) at diagnosis of fetal growth restriction (FGR) on obstetric management and rates of live birth and survival for very preterm infants with early-onset FGR.Population-based cohort study.All maternity units in 25 French regions in 2011.Fetuses diagnosed with FGR before 28 weeks of gestation among singleton

2017 EvidenceUpdates

57. Investigation and Management Small-for-Gestational-Age Fetus

plots below the 10 th centile or serial measurements which demonstrate slow or static growth by crossing centiles should be referred for ultrasound measurement of fetal size. Women in whom measurement of SFH is inaccurate (for example: BMI > 35, large fibroids, hydramnios) should be referred for serial assessment of fetal size using ultrasound. Optimum method of diagnosing a SGA fetus and FGR Fetal abdominal circumference (AC) or estimated fetal weight (EFW) +2 SDs above mean for gestational age (...) three studies included in this review that looked at prediction of early onset SGA, all of which were in low risk/unselected populations. 55 Increased PI in the second trimester has been shown to be predictive of delivery of a SGA fetus 35, large fibroids, hydramnios) should be referred for serial assessment of fetal size using ultrasound. Cohort and case–control studies performed in low risk populations have consistently shown abdominal palpation to be of limited accuracy in the detection of a SGA

2013 Royal College of Obstetricians and Gynaecologists

58. Fetal Head Circumference

Fetal Head Circumference Fetal Head Circumference Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Fetal Head Circumference Fetal Head (...) Circumference Aka: Fetal Head Circumference II. Technique Same view as Biparietal Diameter Less shape dependent Use ellipse III. Equation = BPD + 3mm + OFD x 1.57 Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Fetal Head Circumference." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Related Topics in Radiology About FPnotebook.com is a rapid access, point

2015 FP Notebook

59. The validity of the viscero-abdominal disproportion ratio for type of surgical closure in all fetuses with an omphalocele. Full Text available with Trip Pro

The validity of the viscero-abdominal disproportion ratio for type of surgical closure in all fetuses with an omphalocele. To determine the predictive value of the fetal omphalocele circumference/abdominal circumference (OC/AC) ratio for type of surgical closure and survival and to describe the trajectory of OC/AC ratio throughout gestation.This cohort study included all live-born infants prenatally diagnosed with an omphalocele in our tertiary centre (2000-2017) with an intention to treat

2019 Prenatal diagnosis

60. Comparison of the INTERGROWTH-21st, National Institute of Child Health and Human Development, and WHO fetal growth standards. (Abstract)

in six states in the USA between November 1987 and May 1991. The predictive capability of various biometric indicators (biparietal diameter, femur length, abdominal circumference, head circumference, estimated fetal weight, and birthweight) was evaluated. Adverse outcomes included severe morbidity and perinatal death.There were 9409 women included. Biometric indicators measured at a gestational age of 18-24 weeks had insufficient predictive sensitivity (range, 4%-47%). By contrast, measurements taken (...) Comparison of the INTERGROWTH-21st, National Institute of Child Health and Human Development, and WHO fetal growth standards. To compare the ability of the INTERGROWTH-21st, National Institute of Child Health and Human Development, and WHO fetal growth standards to identify fetuses at risk of adverse perinatal outcomes.A retrospective analysis was performed among women enrolled in a multicenter randomized controlled trial (Routine Antenatal Diagnostic Imaging with Ultrasound) that was conducted

2018 International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>